- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Critical Care Research and Practice
Volume 2013 (2013), Article ID 435236, 11 pages
The Extent of Ventilator-Induced Lung Injury in Mice Partly Depends on Duration of Mechanical Ventilation
1Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
2Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
3Department of Intensive Care, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Received 10 January 2013; Revised 15 March 2013; Accepted 17 March 2013
Academic Editor: Djillali Annane
Copyright © 2013 Maria A. Hegeman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. Mechanical ventilation (MV) has the potential to initiate ventilator-induced lung injury (VILI). The pathogenesis of VILI has been primarily studied in animal models using more or less injurious ventilator settings. However, we speculate that duration of MV also influences severity and character of VILI. Methods. Sixty-four healthy C57Bl/6 mice were mechanically ventilated for 5 or 12 hours, using lower tidal volumes with positive end-expiratory pressure (PEEP) or higher tidal volumes without PEEP. Fifteen nonventilated mice served as controls. Results. All animals remained hemodynamically stable and survived MV protocols. In both MV groups, PaO2 to FiO2 ratios were lower and alveolar cell counts were higher after 12 hours of MV compared to 5 hours. Alveolar-capillary permeability was increased after 12 hours compared to 5 hours, although differences did not reach statistical significance. Lung levels of inflammatory mediators did not further increase over time. Only in mice ventilated with increased strain, lung compliance declined and wet to dry ratio increased after 12 hours of MV compared to 5 hours. Conclusions. Deleterious effects of MV are partly dependent on its duration. Even lower tidal volumes with PEEP may initiate aspects of VILI after 12 hours of MV.
Increased strain due to mechanical ventilation (MV) has the potential to aggravate existing lung injury . Indeed, one meta-analysis shows intensive care unit (ICU) patients with acute respiratory distress syndrome (ARDS) to benefit from MV with lower tidal volume VT . MV with too high VT even has the potential to induce lung injury . This is confirmed in a more recent meta-analysis that shows patients without ARDS at onset of MV to benefit from MV with lower VT as well . Importantly, this meta-analysis also showed beneficial effects of lower VT in patients receiving MV during general anesthesia for surgery .
The potential of MV to aggravate or initiate lung injury was originally proposed in animal models and focused merely on size of VT. Indeed, the so-called ventilator-induced lung injury (VILI) was demonstrated in models of MV in animals with injured lungs . These models revealed that use of high VT worsened the proinflammatory response, disturbed alveolar fibrin turnover, and increased alveolar-capillary permeability resulting in accumulation of protein-rich edema and finally loss of pulmonary function. VILI was also observed in ventilated animals with noninjured lungs [6–10], confirming clinical studies, which suggest that conventional MV has the capability to initiate lung injury by itself. Most interestingly, even MV with lower VT is recently found to induce VILI in healthy animals [11–13].
Animal models with variable durations of MV are important for preclinical testing of ventilator settings, as duration of surgical procedures may vary significantly. Moreover, a vast number of patients may need additional postoperative MV, especially after major surgery. Although the evolution of VILI has been studied even beyond 24 hours in large animal models [14, 15], studies testing the effect of duration of MV on development of VILI are limited in smaller animals like mice. One important advantage of mice above larger animals is the possible application of transgenic or knockout models. Therefore, the aim of the present study was to compare the effects after 12 hours of MV with those after 5 hours in an established model of VILI in healthy mice, that is, without preexisting lung injury. Different VT and positive end-expiratory pressure (PEEP) levels were used to create two opposing ventilation strategies, a strategy with lower VT and PEEP (LVT/PEEP) or a strategy with higher VT and zero PEEP (HVT/ZEEP). We hypothesized that the deleterious effects of MV are not only dependent on its strategy but also on its duration.
The animal care and use committee of the Academic Medical Center, Amsterdam, the Netherlands, approved all experiments. Animal handling was in accordance with institutional standards for care and use of laboratory animals.
Seventy-nine male C57Bl/6 mice (26–30 grams) were randomly assigned to different experimental groups. Sixty-four mice were randomized to MV and fifteen mice were randomized to nonventilated controls (NVC). All mice were without preexisting lung injury at time of randomization.
2.3. Animal Handling
Mice received an intraperitoneal bolus of 1 mL 0.9% saline. After 1 hour, mice were randomized to MV or NVC. Mice that were randomized to MV received an induction of anesthesia via intraperitoneal injection of a mix containing 126 mg/kg ketamine (Eurovet Animal Health B.V., Bladel, the Netherlands), 0.1 mg/kg dexmedetomidine (Pfizer Animal Health B.V., Capelle aan den IJssel, the Netherlands) and 0.5 mg/kg atropine (Pharmachemie, Haarlem, the Netherlands). Maintenance anesthesia was administered via an intraperitoneal cathether every hour and consisted of 36 mg/kg ketamine, 0.02 mg/kg dexmedetomidine and 0.075 mg/kg atropine. Sodium bicarbonate was administered via an intraperitoneal cathether every 30 minutes to maintain bicarbonate levels within the physiological range (22–26 mM). No muscle relaxants were used. Body temperature was kept between 36.5 and 37.5°C.
2.4. Mechanical Ventilation
After insertion of a tracheotomy tube (1.3 mm outer diameter and 0.8 mm inner diameter), mice were connected to a Babylog 8000 plus ventilator (Draeger Medical, Lubeck, Germany) and mechanically ventilated for 5 or 12 hours using a pressure-controlled, volume-targeted approach, at a fractional inspired oxygen concentration (FiO2) of 0.5 and an inspiration-to-expiration ratio of 1 : 3. A pneumotachograph was used for monitoring and continuous regulation of VT (capillary tube, PTM T16375; HSE-Harvard Apparatus, March-Hugstetten, Germany). VT was recorded using respiration software (HSE-BDAS basic data acquisition, HSE-Harvard Apparatus); delivered pressure was regularly adapted to deliver target VT.
2.5. Study Groups
Mice that were randomized to MV were mechanically ventilated with lower VT (~7 mL/kg) and PEEP of 3 cmH2O (LVT/PEEP) or with higher VT (~15 mL/kg) and PEEP of 0 cmH2O (HVT/ZEEP). Respiratory rate was set at 160 or 52 breaths per minute, respectively, aiming at normal pH (7.35–7.45). A recruitment maneuver was performed every 30 minutes during LVT/PEEP and every 60 minutes during HVT/ZEEP by applying an inspiratory hold for 5 seconds, with increased inspiratory pressures when necessary, aiming at normal PaCO2 (35–45 mmHg). The last recruitment maneuver was performed 30 or 60 minutes before blood sampling (LVT/PEEP and HVT/ZEEP, resp.), which was similar in mice ventilated for 5 or 12 hours.
Systolic blood pressure and heart rate were noninvasively monitored using a tail-cuff system for mice (ADInstruments, Spenbach, Germany). Peripheral oxygen saturation (SpO2) was noninvasively measured using a pulse oximeter applied to the mouse hind paw (Siemens Medical Systems, Danvers, MA, USA). After 5 or 12 hours of MV, arterial blood was taken from the carotid artery for blood gas analysis (RAPIDPoint 405; Siemens Healthcare Diagnostics, Tarrytown, NY, USA).
Compliance of the respiratory system was calculated using , in which is the static compliance (mL/cmH2O), and is the plateau pressure (cmH2O). VT was determined using the pneumotachograph. and PEEP were displayed on the mechanical ventilator. The respiration software revealed a decelerating flow curve during both inspiration and expiration, and a square-wave pressure curve (hourly monitored).
2.7. Lung Tissue
Lung tissue was harvested and processed as previously described [13, 16]. From a first series of mice ( = 6–8 per group), the right lung was used to obtain bronchoalveolar lavage fluid (BALF) and the left lung was used for wet to dry ratios. From a second series of mice ( = 6–8 per group), the right lung was snap frozen to obtain lung homogenates and the left lung used for histopathology.
Interleukin (IL)-1β, IL-6, keratinocyte-derived chemokine (KC), and macrophage inflammatory protein- (MIP)-2 levels were measured in total lung homogenates and receptor for advanced glycation endproducts (RAGE) levels were measured in BALF by ELISA (R&D systems, Minneapolis, MN, USA). Total protein levels were determined in BALF using a Bradford Protein Assay Kit according to manufacturer’s instructions with bovine serum albumin as standard (OZ Biosciences, Marseille, France). Immunoglobulin (Ig)M levels were measured in BALF by ELISA as previously described .
2.9. Statistical Analysis
Data are presented as median (IQR) or scatter plot (median), as appropriate. Since group characteristics did not follow a normal distribution, differences between groups were analyzed by Kruskal-Wallis tests with post hoc Mann-Whitney tests and Bonferroni correction. We first compared 12 hours of MV with 5 hours or NVC ( value for significance was set at 0.0125); next we compared LVT/PEEP with HVT/ZEEP ventilation at 12 hours ( value for significance was set at 0.01). Seven mice were excluded from analysis because of various reasons (i.e., blood in BALF (), unstable blood pressure (), and unreliable cell count measurement ).
3.1. Hemodynamic and Respiratory Parameters
All mice were ventilated in a pressure-controlled, volume-targeted approach. In LVT/PEEP ventilated mice, VT was maintained at 7.0 mL/kg by delivering a of 11.0 cmH2O throughout 12 hours of MV (Table 1(A)). In HVT/ZEEP ventilated mice, VT was maintained at 15.0 mL/kg by delivering a of 20.0 cmH2O at 5 hours of MV increasing to 25.5 cmH2O at 12 hours. All animals survived the experimental procedures throughout 5 or 12 hours of MV. Systolic blood pressures and heart rates remained stable and SpO2 levels remained ≥90% during 5 or 12 hours of MV, independent of ventilation strategy (Figure 1). PaCO2, pH, base excess, and levels remained within normal to near-normal range in all series of experiments (Table 1(B)). In both MV groups, PaO2 to FiO2 ratios were lower after 12 hours of MV compared to 5 hours (Figure 2(a)). Lung compliances were also lower after 12 hours of MV compared to 5 hours in mice ventilated with HVT/ZEEP, but not in mice ventilated with LVT/PEEP (Figure 2(b)).
3.2. Edema Formation and Alveolar-Capillary Permeability
Lung wet to dry ratios were higher after 12 hours of MV compared to 5 hours in mice ventilated with HVT/ZEEP, but not in mice ventilated with LVT/PEEP (Figure 3(a)). Lung wet to dry ratios showed a negative correlation with lung compliances, especially in HVT/ZEEP-ventilated mice (Figure 3(b)). BALF total protein, IgM, and RAGE levels tended to be higher after 12 hours of MV compared to 5 hours in both ventilation groups, although only with statistical significance for IgM in mice ventilated with HVT/ZEEP (Figures 4(a)–4(c)).
3.3. Cell Infiltration
BALF cell contents were elevated after 12 hours of MV compared to 5 hours, independent of ventilation strategy (Figure 5(a)). BALF neutrophil counts were higher after 12 hours of MV compared to 5 hours in both ventilation groups, although differences did not reach statistical significance when comparing 12 with 5 hours of MV in mice ventilated with LVT/PEEP (Figure 5(b)). BALF macrophage counts were elevated after 12 hours of MV compared to 5 hours in mice ventilated with LVT/PEEP, but not in mice ventilated with HVT/ZEEP (Figure 5(c)).
3.4. Inflammatory Mediators
Lung IL-1β, IL-6, KC, and MIP-2 levels increased after 12 hours of MV compared to NVC in both ventilation groups, except for MIP-2 levels in mice ventilated with LVT/PEEP (Figures 6(a)–6(d)). In addition, lung IL-1β and MIP-2 levels were higher after 12 hours of MV compared to 5 hours in mice ventilated with HVT/ZEEP, although differences in MIP-2 levels did not reach statistical significance (Figures 6(a) and 6(d)).
3.5. Lung Histopathology
Histopathological changes due to MV were minor and were recognizable as edema formation and interstitial infiltration of inflammatory cells (Figure 7). Differences in total histopathology score were only observed between 12 hours of HVT/ZEEP ventilation and NVC (Table 2).
3.6. Differences between MV Strategies
Differences between the two ventilation groups after 12 hours of MV confirm previous findings, with more lung injury with HVT/ZEEP as compared to LVT/PEEP ventilation. These differences include lung wet to dry ratios (Figure 3(a)), BALF total protein levels (Figure 4(a)), BALF RAGE levels (Figure 4(c)), lung IL-1β levels (Figure 6(a)), lung IL-6 levels (Figure 6(b)), lung KC levels (Figure 6(c)), and total histopathology score (Table 2). In contrast, BALF macrophage numbers were higher after 12 hours of LVT/PEEP ventilation compared to 12 hours of HVT/ZEEP ventilation (Figure 5(c)).
The present study shows that the appearance of VILI depends not only on the strategy but also on the duration of MV. Indeed, well-known characteristics of VILI evolved over time, with longer duration of MV having a greater effect in strategies with HVT/ZEEP than in strategies with LVT/PEEP. Moreover, lung injury is even caused by less injurious MV settings when extending the duration.
The results of the present study are, at least in part, in line with previous clinical and animal studies showing that MV has the potential to cause lung injury in healthy lungs. Indeed, two retrospective studies of patients without ARDS at onset of MV suggest that MV with high VT is a risk factor for developing lung injury [19, 20]. A more recent randomized controlled trial provides additional evidence by showing that MV with lower VT prevents lung injury in critically ill patients without ARDS at onset of MV . Previous animal studies confirmed that mice with noninjured lungs can develop VILI when exposed to MV [6–10]. Thus, preexisting lung injury is not a prerequisite for the devastating effects of MV. The current finding that even less injurious MV settings can cause lung injury is in line with previous animal studies [11–13]. It should be noted that the majority of small animal investigations studied the effects of MV over relatively short durations. Our data in mice show that the phenotype of VILI changes with duration of MV. Alveolar-capillary barrier dysfunction and inflammation are early features of VILI. Decrease in PaO2 to FiO2 ratios is observed after a longer duration of MV, whereas neutrophil infiltration was most pronounced after 12 hours of MV. These findings suggest that development of VILI not only progresses but also evolves over time. Thus, small animal investigations using shorter-lasting MV may have underestimated the severity and time-dependent character of VILI. In large animal models, the evolution of VILI beyond 24 hours has been described before [14, 15].
There is convincing evidence that even MV during general anesthesia for surgery has the potential to initiate subtle pulmonary changes [22–26]. In addition, postoperative pulmonary complications add to the morbidity and mortality of surgical patients [27, 28] and clinical studies suggest that less injurious MV settings in the perioperative period may reduce postoperative respiratory morbidity [24, 29–31]. As smaller animals have different respiratory mechanisms than humans [32, 33] and are less resistant to VILI , it should be taken into account that the effect of MV in the experimental setting may not be completely comparable to the clinical setting. Considering the duration of MV used in animal models so far, one could argue that current animal models better reflect the clinical scenario of patients who require general anesthesia for surgery than those who require intensive care. In view of this notion, experimental studies using longer durations of MV may therefore mimic the clinical scenario of patients who need MV for longer-lasting surgical procedures, or patients who need postoperative MV for several hours.
Previous clinical studies clearly show that it makes a difference as far which ventilator settings are being used during the perioperative phase of major surgery [23, 35]. Although clinical trials about the effects of ventilation strategies in the postoperative setting are lacking, it has been suggested that the use lower VT should be considered in all mechanically ventilated patients . Present experimental data may contribute to our understanding of optimal ventilator strategies in patients who need postoperative MV for several hours. This study confirms that extent of VILI is dependent on the used VT. In addition, this study demonstrates that 5 hours of MV may not be as detrimental as 12 hours of MV. So, it may be important to consider that the aspects of VILI are not only critically influenced by VT, but also by duration of MV. Indeed, 12 hours of LVT/PEEP ventilation appeared to induce important aspects of VILI as well. Interestingly, increased macrophage numbers were observed after 12 hours of LVT/PEEP ventilation but not after 12 hours of HVT/ZEEP ventilation. The failure to recover BALF macrophages after 12 hours of HVT/ZEEP could suggest macrophage activation and adhesion to lung tissue which may account for orchestrating the increase in proinflammatory mediators and recruitment of neutrophils. Recent studies, however, revealed the importance of macrophages in the termination and resolution of inflammation . Therefore, an alternative explanation is that the presence of more macrophages after 12 hours of LVT/PEEP ventilation could play a protective role in the development of VILI. It has been previously shown that macrophages are involved in tissue repair and as a result capable of restoring lung barrier integrity . Supporting the latter explanation, a negative correlation was found between BALF macrophage numbers and wet to dry ratios in LVT/PEEP-ventilated mice (Pearson with ). Future studies need to address the differential effects of MV settings and duration on BALF macrophage numbers and evaluate the exact role of macrophages in the development of VILI. Another negative correlation was found between lung wet to dry ratios and compliances in both MV groups. This finding supports the rationale that accumulation of interstitial and alveolar edema decreases compliance of the respiratory system as gas in small airways becomes displaced with fluid . Lung compliance and wet to dry ratio were only altered in mice ventilated with HVT/ZEEP for 12 hours, which may reflect that more time is required for enhanced microvascular permeability and subsequent fluid filtration into the interstitial and alveolar space.
The present study knows several limitations. First, clinically relevant VT that closely reflect current MV practice in critically ill patients were used. Within this range of clinically relevant VT, we restricted the experimental design to a “less” and “more” injurious MV strategy (LVT/PEEP and HVT/ZEEP, resp.). Second, it has been described that mice have different respiratory mechanisms than humans [32, 33]. Moreover, smaller species have less resistance to VILI than larger species . Therefore, a tidal volume of 7 mL/kg may have a greater effect in mice than in humans, where it is considered a protective ventilator setting. In addition, the lifespan of mice is much shorter compared to that of humans making 12 hours of MV relatively longer in mice than in humans. These differences in physiology may hamper the translation of current results to the human situation. Third, the analysis was restricted to some well-known characteristics of VILI such as the proinflammatory response, immune cell infiltration, alveolar-capillary permeability, and lung function. And fourth, the effects of MV were studied in otherwise healthy mice. The effects of longer duration of MV may be even more distinct in mice with lung injury.
In healthy mice, longer duration of MV aggravates important aspects of VILI compared to shorter-lasting MV or spontaneous breathing, with the phenotype of VILI changing over time. Furthermore, even less injurious ventilator settings may induce important aspects of VILI after 12 hours of MV. Thus, when interpreting data from animal studies, it is important to realize that deleterious effects of MV are dependent not only on its strategy but also on its duration.
The authors thank for expert assistance with the statistical analysis: Dr. J. M. Binnekade (statistician), Department of Intensive Care, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
- A. Malhotra, “Low-tidal-volume ventilation in the acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 357, no. 11, pp. 1113–1120, 2007.
- C. Putensen, N. Theuerkauf, J. Zinserling, H. Wrigge, and P. Pelosi, “Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury,” Annals of Internal Medicine, vol. 151, no. 8, pp. 566–576, 2009.
- M. J. Schultz, J. J. Haitsma, A. S. Slutsky, and O. Gajic, “What tidal volumes should be used in patients without acute lung injury?” Anesthesiology, vol. 106, no. 6, pp. 1226–1231, 2007.
- A. S. Neto, S. O. Cardoso, J. A. Manetta, et al., “Association between use of lung protective ventilation with lower tidal volumes and risk of acute lung injury, mortality, pulmonary infection and atelectasis—a meta-analysis,” Journal of the American Medical Association, vol. 308, no. 16, pp. 1651–1659, 2012.
- D. Dreyfuss and G. Saumon, “Ventilator-induced lung injury: lessons from experimental studies,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 1, pp. 294–323, 1998.
- J. A. Belperio, M. P. Keane, M. D. Burdick et al., “Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury,” Journal of Clinical Investigation, vol. 110, no. 11, pp. 1703–1716, 2002.
- I. B. Copland, F. Martinez, B. P. Kavanagh et al., “High tidal volume ventilation causes different inflammatory responses in newborn versus adult lung,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 6, pp. 739–748, 2004.
- J. J. Haitsma, S. Uhlig, S. J. Verbrugge, R. Göggel, D. L. H. Poelma, and B. Lachmann, “Injurious ventilation strategies cause systemic release of IL-6 and MIP-2 in rats in vivo,” Clinical Physiology and Functional Imaging, vol. 23, no. 6, pp. 349–353, 2003.
- M. R. Wilson, S. Choudhury, M. E. Goddard, K. P. O'Dea, A. G. Nicholson, and M. Takata, “High tidal volume upregulates intrapulmonary cytokines in an in vivo mouse model of ventilator-induced lung injury,” Journal of Applied Physiology, vol. 95, no. 4, pp. 1385–1393, 2003.
- M. R. Wilson, S. Choudhury, and M. Takata, “Pulmonary inflammation induced by high-stretch ventilation is mediated by tumor necrosis factor signaling in mice,” American Journal of Physiology, vol. 288, no. 4, pp. L599–L607, 2005.
- P. M. Cobelens, B. P. van Putte, A. Kavelaars, C. J. Heijnen, and J. Kesecioglu, “Inflammatory consequences of lung ischemia-reperfusion injury and low-pressure ventilation,” Journal of Surgical Research, vol. 153, no. 2, pp. 295–301, 2009.
- M. Vaneker, F. J. Halbertsma, J. van Egmond et al., “Mechanical ventilation in healthy mice induces reversible pulmonary and systemic cytokine elevation with preserved alveolar integrity: an in vivo model using clinical relevant ventilation settings,” Anesthesiology, vol. 107, no. 3, pp. 419–426, 2007.
- E. K. Wolthuis, A. P. Vlaar, G. Choi, J. J. Roelofs, N. P. Juffermans, and M. J. Schultz, “Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice,” Critical Care, vol. 13, no. 1, article R1, 2009.
- S. Mandava, T. Kolobow, G. Vitale et al., “Lethal systemic capillary leak syndrome associated with severe ventilator-induced lung injury: an experimental study,” Critical Care Medicine, vol. 31, no. 3, pp. 885–892, 2003.
- K. Tsuno, P. Prato, and T. Kolobow, “Acute lung injury from mechanical ventilation at moderately high airway pressures,” Journal of Applied Physiology, vol. 69, no. 3, pp. 956–961, 1990.
- M. A. Hegeman, M. P. Hennus, M. van Meurs et al., “Angiopoietin-1 treatment reduces inflammation but does not prevent ventilator-induced lung injury,” PLoS ONE, vol. 5, no. 12, Article ID e15653, 2010.
- R. M. Reijmers, R. W. J. Groen, A. Kuil et al., “Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival,” Blood, vol. 117, no. 23, pp. 6162–6171, 2011.
- T. Uchida, M. Shirasawa, L. B. Ware et al., “Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 9, pp. 1008–1015, 2006.
- O. Gajic, S. I. Dara, J. L. Mendez et al., “Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation,” Critical Care Medicine, vol. 32, no. 9, pp. 1817–1824, 2004.
- O. Gajic, F. Frutos-Vivar, A. Esteban, R. D. Hubmayr, and A. Anzueto, “Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients,” Intensive Care Medicine, vol. 31, no. 7, pp. 922–926, 2005.
- R. M. Determann, A. Royakkers, E. K. Wolthuis et al., “Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial,” Critical Care, vol. 14, no. 1, article R1, 2010.
- G. Choi, E. K. Wolthuis, P. Bresser et al., “Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury,” Anesthesiology, vol. 105, no. 4, pp. 689–695, 2006.
- M. Licker, J. Diaper, Y. Villiger et al., “Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery,” Critical Care, vol. 13, no. 2, article R41, 2009.
- P. Michelet, X. B. D'Journo, A. Roch et al., “Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study,” Anesthesiology, vol. 105, no. 5, pp. 911–919, 2006.
- E. K. Wolthuis, G. Choi, M. C. Dessing et al., “Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury,” Anesthesiology, vol. 108, no. 1, pp. 46–54, 2008.
- E. Zupancich, D. Paparella, F. Turani et al., “Mechanical ventilation affects inflammatory mediators in patients undergoing cardiopulmonary bypass for cardiac surgery: a randomized clinical trial,” Journal of Thoracic and Cardiovascular Surgery, vol. 130, no. 2, pp. 378–383, 2005.
- A. M. Arozullah, J. Daley, W. G. Henderson, and S. F. Khuri, “Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery,” Annals of Surgery, vol. 232, no. 2, pp. 242–253, 2000.
- G. W. Smetana, V. A. Lawrence, and J. E. Cornell, “Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians,” Annals of Internal Medicine, vol. 144, no. 8, pp. 581–595, 2006.
- M. A. Chaney, M. P. Nikolov, B. P. Blakeman, and M. Bakhos, “Protective ventilation attenuates postoperative pulmonary dysfunction in patients undergoing cardiopulmonary bypass,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 14, no. 5, pp. 514–518, 2000.
- P. G. Lee, C. M. Helsmoortel, S. M. Cohn, and M. P. Fink, “Are low tidal volumes safe?” Chest, vol. 97, no. 2, pp. 430–434, 1990.
- M. Yang, H. J. Ahn, K. Kim et al., “Does a protective ventilation strategy reduce the risk of pulmonary complications after lung cancer surgery?: a randomized controlled trial,” Chest, vol. 139, no. 3, pp. 530–537, 2011.
- S. E. Soutiere and W. Mitzner, “On defining total lung capacity in the mouse,” Journal of Applied Physiology, vol. 96, no. 5, pp. 1658–1664, 2004.
- G. R. Zosky, T. Z. Janosi, A. Adamicza et al., “The bimodal quasi-static and dynamic elastance of the murine lung,” Journal of Applied Physiology, vol. 105, no. 2, pp. 685–692, 2008.
- P. Caironi, T. Langer, E. Carlesso, et al., “Time to generate ventilator-induced lung injury among mammals with healthy lungs: a unifying hypothesis,” Intensive Care Medicine, vol. 37, no. 12, pp. 1913–1920, 2011.
- F. Lellouche, S. Dionne, S. Simard, et al., “High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery,” Anesthesiology, vol. 116, no. 5, pp. 1072–1082, 2012.
- S. Herold, K. Mayer, and J. Lohmeyer, “Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair,” Frontiers in Immunology, vol. 2, article 65, 2011.
- J. C. Parker and M. I. Townsley, “Evaluation of lung injury in rats and mice,” American Journal of Physiology, vol. 286, no. 2, pp. L231–L246, 2004.